Table 4.
Comparison of demographics and comorbidities between with and without diagnostic ureteroscopy in patients with upper tract urothelial carcinoma
| URS+ | URS- | P-value | |
|---|---|---|---|
| Mean±SD/ (N,%) | Mean±SD/ (N,%) | ||
| 3,079 (53.9) | 2,634 (46.1) | ||
| Gender | |||
| Male (N, %) | 1,346 (43.72%) | 1,126 (42.75%) | 0.462 |
| Female (N, %) | 1,733 (56.28%) | 1,508 (57.25%) | |
| Age (Mean±SD) | 67.79 (±10.68) | 67.63 (±11.15) | 0.599 |
| Age (N,%) | |||
| <65 years | 1,092 (35.47%) | 952 (36.14%) | 0.491 |
| 65-74 years | 1,150 (37.35%) | 944 (35.84%) | |
| >74 years | 837 (27.18%) | 738 (28.02%) | |
| CCI score (N,%) | |||
| 0 | 272 (8.83%) | 341 (12.95%) | <0.001* |
| 1 | 217 (7.05%) | 245 (9.30%) | |
| ≧2 | 2,590 (84.12%) | 2,048 (77.75%) | |
| Comorbidity | |||
| Hypertension | |||
| No | 1,443 (46.87%) | 1,300 (49.35%) | 0.061 |
| Yes | 1,636 (53.13%) | 1,334 (50.65%) | |
| Hyperlipidemia | |||
| No | 2,371 (77.01%) | 2,138 (81.17%) | <0.001* |
| Yes | 708 (22.99%) | 496 (18.83%) | |
| Diabetes | |||
| No | 2,345 (76.16%) | 2,054 (77.98%) | 0.103 |
| Yes | 734 (23.84%) | 580 (22.02%) | |
| ESRD | |||
| No | 2,490 (80.87%) | 2,072 (78.66%) | 0.038* |
| Yes | 589 (19.13%) | 562 (21.34%) | |
CCI Charlson Comorbidity Index, ESRD End-stage renal disease
*p<0.05